awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37858327-4B50BC90-B502-46F8-AE0F-26F4F79A1CF9
Q37858327-4B50BC90-B502-46F8-AE0F-26F4F79A1CF9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37858327-4B50BC90-B502-46F8-AE0F-26F4F79A1CF9
Multiple myeloma treatment strategies with novel agents in 2011: a European perspective
P2860
Q37858327-4B50BC90-B502-46F8-AE0F-26F4F79A1CF9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37858327-4B50BC90-B502-46F8-AE0F-26F4F79A1CF9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
41c21b39fc92b4db95c4bc0b796c862dbd4b6011
P2860
The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma.